Bend Research Aids Flu Vaccines

November 29, 2012
Bend Bulletin

Bend Research Inc. has developed new technology that could increase the lifespan of common influenza vaccines. Bend Research, working alongside the Seattle-based Path company and Michigan biotechnology company Fraunhofer USA, announced its development of a new spray-drying process, which could make vaccines effective for longer periods of time, according to a joint news release issued Wednesday. Scientists use a method called spray-drying to prevent vaccines from becoming diluted or insoluble. The process essentially turns a liquid solution into a dry powder-like substance, which maintains its chemical properties for longer periods of time in storage than a liquid solution. The spray-drying method developed by Bend Research developed an influenza vaccine that remained stable at 50 degrees Celsius for more than two months, according to the release.